Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Journal of Pediatrics
Erschienen in: European Journal of Pediatrics 2/2007

01.02.2007 | Review

Familial and acquired hemophagocytic lymphohistiocytosis

verfasst von: Gritta E. Janka

Erschienen in: European Journal of Pediatrics | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition of severe hyperinflammation caused by the uncontrolled proliferation of activated lymphocytes and histiocytes secreting high amounts of inflammatory cytokines. Cardinal signs and symptoms are prolonged fever, hepatosplenomegaly and pancytopenia. Characteristic biochemical markers include elevated triglycerides, ferritin and low fibrinogen. HLH occurs on the basis of various inherited or acquired immune deficiencies. Impaired function of natural killer (NK) cells and cytotoxic T-cells (CTL) is shared by all forms of HLH. Genetic HLH occurs in familial forms (FHLH) in which HLH is the primary and only manifestation, and in association with the immune deficiencies Chédiak-Higashi syndrome 1 (CHS 1), Griscelli syndrome 2 (GS 2) and x-linked lymphoproliferative syndrome (XLP), in which HLH is a sporadic event. Most patients with acquired HLH have no known underlying immune deficiency. Both acquired and genetic forms are triggered by infections, mostly viral, or other stimuli. HLH also occurs as a complication of rheumatic diseases (macrophage activation syndrome) and of malignancies. Several genetic defects causing FHLH have recently been discovered and have elucidated the pathophysiology of HLH. The immediate aim of therapy in genetic and acquired HLH is suppression of the severe hyperinflammation, which can be achieved with immunosuppressive/immunomodulatary agents and cytostatic drugs. Patients with genetic forms have to undergo stem cell transplantation to exchange the defective immune system with normally functioning immune effector cells.
In conclusion, awareness of the clinical symptoms and of the diagnostic criteria of HLH is crucial in order not to overlook HLH and to start life-saving therapy in time.
Literatur
1.
Allen M, De Fusco C, Legrand F, Clementi R, Conter V, Danesino C, Janka G, Arico M (2001) Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica 86:499–503PubMed
2.
Almousa H, Ouachee-Chardin M, Picard C, Radford-Weiss I, Caillat-Zucman S, Cavazzana-Calvo M, Blanche S, de Saint Basile G, Le Deist F, Fischer A (2005) Transient familial haemophagocytic lymphohistiocytosis reactivation post-CD34 haematopoietic stem cell transplantation. Br J Haematol 130:404–408PubMed
3.
Ambruso DR, Hays T, Zwartjes WJ, Tubergen DG, Favara BE (1980) Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer 45:2516–2520PubMed
4.
Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP (1996) Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 10:197–203PubMed
5.
Arico M, Nespoli L, Maccario R, Montagna D, Bonetti F, Caselli D, Burgio GR (1988) Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child 63:292–296PubMed
6.
Baker KS, DeLaat CA, Steinbuch M, Gross TG, Shapiro RS, Loechelt B, Harris R, Filipovich AH (1997) Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood 89:3857–3863PubMed
7.
Bejaoui M, Veber F, Girault D, Gaud C, Blanche S, Griscelli C, Fischer A (1989) The accelerated phase of Chediak-Higashi syndrome. Arch Fr Pediatr 46:733–736PubMed
8.
Beutel K, Janka GE, Schneider ME (2002) EBV-associated hemophagocytic lymphohistiocytosis (HLH) in German children. Med Pediatr Oncol 38:224
9.
Blanche S, Caniglia M, Girault D, Landman J, Griscelli C, Fischer A (1991) Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases. Blood 78:51–54PubMed
10.
Chen R, Relouzat F, Roncagalli R, Aoukaty A, Tan R, Latour S, Veillette A (2004) Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol Cell Biol 24:5144–5156PubMed
11.
Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, Su IJ (2005) Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 106:3090–3096PubMed
12.
Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C, Arico M (2002) Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 100:2266–2267PubMed
13.
Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20:129–135PubMed
14.
Cooper N, Rao K, Gilmour K, Hadad L, Adams S, Cale C, Davies G, Webb D, Veys P, Amrolia P (2006) Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 107:1233–1236PubMed
15.
Dürken M, Horstmann M, Bieling P, Erttmann R, Kabisch H, Loliger C, Schneider EM, Hellwege HH, Kruger W, Kroger N, Zander AR, Janka GE (1999) Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. Br J Haematol 106:1052–1058PubMed
16.
Duval M, Fenneteau O, Doireau V, Faye A, Emilie D, Yotnda P, Drapier JC, Schlegel N, Sterkers G, de Baulny HO, Vilmer E (1999) Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 134:236–239PubMed
17.
Eife R, Janka GE, Belohradsky BH, Holtmann H (1989) Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 6:265–272PubMedCrossRef
18.
Falini B, Pileri S, De Solas I, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75:434–444PubMed
19.
Farquhar JW, Claireaux AE (1952) Familial haemophagocytic reticulosis. Arch Dis Child 27:519–525PubMed
20.
Favara BE (1996) Histopathology of the liver in histiocytosis syndromes. Pediatr Pathol Lab Med 16:413–433PubMed
21.
Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachee-Chardin M, Chedeville G, Tamary H, Minard-Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G (2003) Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115:461–473PubMed
22.
Feldmann J, Menasche G, Callebaut I, Minard-Colin V, Bader-Meunier B, Le Clainche L, Fischer A, Le Deist F, Tardieu M, de Saint Basile G (2005) Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. Blood 105:2658–2663PubMed
23.
Ferlazzo G, Munz C (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333–1339PubMed
24.
Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405–411PubMed
25.
Filipovich A (2002) Hemophagocytic lymphohistiocytosis. Immunol Allergy Clin N Am 22:281–300
26.
Filipovich AH (2005) Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. Pediatr Transplant 9 Suppl 7:87–91PubMed
27.
Fischer A, Cerf-Bensussan N, Blanche S, Le Deist F, Bremard-Oury C, Leverger G, Schaison G, Durandy A, Griscelli C (1986) Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 108:267–270PubMed
28.
Fitzgerald NE, McClain KL (2003) Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol 33:392–401PubMed
29.
Fruman DA, Burakoff SJ, Bierer BE (1994) Immunophilins in protein folding and immunosuppression. Faseb J 8:391–400PubMed
30.
Gagnaire MH, Galambrun C, Stephan JL (2000) Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children–a series of 12 cases. Pediatrics 106:E58PubMed
31.
Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O’Shea JJ, Chrousos GP, Bornstein SR (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. Faseb J 16:61–71PubMed
32.
Gilbert EF, ZuRhein GM, Wester SM, Herrmann J, Hong R, Opitz JM (1985) Familial hemophagocytic lymphohistiocytosis: report of four cases in two families and review of the literature. Pediatr Pathol 3:59–92PubMed
33.
Goldberg J, Nezelof C (1986) Lymphohistiocytosis: a multi-factorial syndrome of macrophagic activation clinico-pathological study of 38 cases. Hematol Oncol 4:275–289PubMed
34.
Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A (2003) Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142:292–296PubMed
35.
Hadchouel M, Prieur AM, Griscelli C (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 106:561–566PubMed
36.
Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 89:794–800PubMed
37.
Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, Sako M, Osugi Y, Nagata S, Sano K (1998) Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 91:2793–2799PubMed
38.
Henter JI, Andersson B, Elinder G, Jakobson A, Lubeck PO, Soder O (1996) Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 27:21–25PubMed
39.
Henter JI, Ehrnst A, Andersson J, Elinder G (1993) Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 82:369–372PubMed
40.
Henter JI, Elinder G (1992) Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet 339:104–107PubMed
41.
Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U (1991) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78:2918–2922PubMed
42.
Henter JI, Elinder G, Soder O, Ost A (1991) Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80:428–435PubMed
43.
Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100:2367–2373PubMed
44.
Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M (2006) Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 81:59–61PubMed
45.
Herlin T, Pallesen G, Kristensen T, Clausen N (1987) Unusual immunophenotype displayed by histiocytes in haemophagocytic lymphohistiocystosis. J Clin Pathol 40:1413–1417PubMed
46.
Hibi S, Ikushima S, Fujiwara F, Hashida T, Tsunamoto K, Todo S, Imashuku S (1995) Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 75:1700–1705PubMed
47.
Horne A, Zheng C, Lorenz I, Löfstedt M, Montgomery SM, Janka G, Henter J-I, Schneider EM (2005) Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistiocytosis provides therapeutic guidance. Br J Haematol 129:658–666PubMed
48.
Horne A, Janka G, Maarten Egeler R, Gadner H, Imashuku S, Ladisch S, Locatelli F, Montgomery SM, Webb D, Winiarski J, Filipovich AH, Henter JI (2005) Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 129:622–630PubMed
49.
Howells DW, Strobel S, Smith I, Levinsky RJ, Hyland K (1990) Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management. Pediatr Res 28:116–119PubMed
50.
Ikeda H, Kato M, Matsunaga A, Shimizu Y, Katsuura M, Hayasaka K (1998) Multiple sulphatase deficiency and haemophagocytic syndrome. Eur J Pediatr 157:553–554PubMed
51.
Imashuku S (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259–272PubMed
52.
Imashuku S, Hibi S, Tabata Y, Sako M, Sekine Y, Hirayama K, Sakazaki H, Maeda N, Kito H, Shichino H, Mugishima H (1998) Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 31:131–137PubMed
53.
Imashuku S, Hibi S, Todo S, Sako M, Inoue M, Kawa K, Koike K, Iwai A, Tsuchiya S, Akiyama Y, Kotani T, Kawamura Y, Hirosawa M, Hasegawa D, Kosaka Y, Yamaguchi H, Ishii E, Kato K, Ishii M, Kigasawa H (1999) Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 23:569–572PubMed
54.
Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S (2001) Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19:2665–2673PubMed
55.
Ishikawa J, Maeda T, Miyazaki T, Manabe N, Honda S, Nishiura T, Tomiyama Y, Matsuzawa Y (2000) Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation. Int J Hematol 72:243–246PubMed
56.
Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M (1983) Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 75:741–749PubMed
57.
Janka G, Müller-Rosenberger, M, Schneider, EM (2001) Persistent defect of cellular cytotoxicity after Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Blood 96:36b
58.
Janka G, Henter, J-I, Imashuku S (2005) Clinical aspects and therapy of hemophagocytic lymphohistiocytosis. In: Weitzman S, Egeler RM (ed) Histiocytic disorders of children and adults. Cambridge University Press, Cambridge, pp 353–379
59.
Janka G, Imashuku S, Elinder G, Schneider M, Henter JI (1998) Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 12:435–444PubMed
60.
Janka GE (1983) Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140:221–230PubMed
61.
Janka GE, Schneider EM (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124:4–14PubMed
62.
Jordan MB, Hildeman D, Kappler J, Marrack P (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104:735–743PubMed
63.
Kapelari K, Fruehwirth M, Heitger A, Konigsrainer A, Margreiter R, Simma B, Offner FA (2005) Loss of intrahepatic bile ducts: an important feature of familial hemophagocytic lymphohistiocytosis. Virchows Arch 446:619–625PubMed
64.
Katano H, Cohen JI (2005) Perforin and lymphohistiocytic proliferative disorders. Br J Haematol 128:739–750PubMed
65.
Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N et al (1993) Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 92:1444–1450PubMedCrossRef
66.
Kieslich M, Vecchi M, Driever PH, Laverda AM, Schwabe D, Jacobi G (2001) Acute encephalopathy as a primary manifestation of haemophagocytic lymphohistiocytosis. Dev Med Child Neurol 43:555–558PubMed
67.
Kikuta H, Sakiyama Y (1995) Etoposide (VP-16) inhibits Epstein-Barr virus determined nuclear antigen (EBNA) synthesis. Br J Haematol 90:971–973PubMed
68.
Klein C, Philippe N, Le Deist F, Fraitag S, Prost C, Durandy A, Fischer A, Griscelli C (1994) Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr 125:886–895PubMed
69.
Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 99:61–66PubMed
70.
Kollias SS, Ball WS Jr, Tzika AA, Harris RE (1994) Familial erythrophagocytic lymphohistiocytosis: neuroradiologic evaluation with pathologic correlation. Radiology 192:743–754PubMed
71.
Komp DM, McNamara J, Buckley P (1989) Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73:2128–2132PubMed
72.
Levy J, Wodell RA, August CS, Bayever E (1990) Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant 6:349–352PubMed
73.
Loechelt BJ, Egeler M, Filipovich AH, Jyonouchi H, Shapiro RS (1994) Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL). Med Pediatr Oncol 22:325–328PubMed
74.
Menasche G, Feldmann J, Fischer A, de Saint Basile G (2005) Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 203:165–179PubMed
75.
Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le Deist F, de Saint Basile G (2000) Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 25:173–176PubMed
76.
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197–223PubMed
77.
Moretta L, Ferlazzo G, Mingari MC, Melioli G, Moretta A (2003) Human natural killer cell function and their interactions with dendritic cells. Vaccine 21 Suppl 2:S38–42PubMed
78.
Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129:750–754PubMed
79.
Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT (1987) Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 111:530–535PubMed
80.
Müller-Rosenberger M (2004) Histiozytyäre Hämophagozytosesyndrome bei Kindern; Klinik, Verlauf und funktionelle Diagnostik. Dissertation University Hamburg, Hamburg
81.
Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault BJ Jr, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ (1996) Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 14:307–311PubMed
82.
Neeft M, Wieffer M, de Jong AS, Negroiu G, Metz CH, van Loon A, Griffith J, Krijgsveld J, Wulffraat N, Koch H, Heck AJ, Brose N, Kleijmeer M, van der Sluijs P (2005) Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells. Mol Biol Cell 16:731–741PubMed
83.
Ohadi M, Lalloz MR, Sham P, Zhao J, Dearlove AM, Shiach C, Kinsey S, Rhodes M, Layton DM (1999) Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am J Hum Genet 64:165–171PubMed
84.
Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89:4100–4103PubMed
85.
Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C, Neven B, Casanova JL, Tardieu M, Cavazzana-Calvo M, Blanche S, Fischer A (2006) Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 117:e743–e750PubMed
86.
Parizhskaya M, Reyes J, Jaffe R (1999) Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 2:360–366PubMed
87.
Perel Y, Alos N, Ansoborlo S, Carrere A, Guillard JM (1997) Dramatic efficacy of antithymocyte globulins in childhood EBV-associated haemophagocytic syndrome. Acta Paediatr 86:911PubMedCrossRef
88.
Perez N, Virelizier JL, Arenzana-Seisdedos F, Fischer A, Griscelli C (1984) Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr 104:569–573PubMed
89.
Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG (1990) Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes). Histopathology 16:383–391PubMed
90.
Poggi A, Costa P, Tomasello E, Moretta L (1998) IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur J Immunol 28:1611–1616PubMed
91.
Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA (2001) Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 28:2120–2124PubMed
92.
Purtilo DT, Grierson HL, Davis JR, Okano M (1991) The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975–1990. Pediatr Pathol 11:685–710PubMed
93.
Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443–451PubMed
94.
Ramanan A, Laxer R, Schneider R (2005) Secondary hemophagocytic syndromes associated with rheumatic diseases. In: Weitzman S ER (ed) Histiocytic disorders of children and adults. Cambridge University Press, Cambridge, pp 380–395
95.
Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548–552PubMed
96.
Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146:598–604PubMed
97.
Reardon DA, Roskos R, Hanson CA, Castle V (1991) Virus-associated hemophagocytic syndrome following bone marrow transplantation. Am J Pediatr Hematol Oncol 13:305–309PubMedCrossRef
98.
Reiner AP, Spivak JL (1988) Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 67:369–388
99.
Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD (1979) Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993–1002PubMed
100.
Risma KA, Frayer RW, Filipovich AH, Sumegi J (2006) Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest 116:182–192PubMed
101.
Ross C, Svenson M, Nielsen H, Lundsgaard C, Hansen MB, Bendtzen K (1997) Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood 90:2376–2380PubMed
102.
Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE (2002) Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 100:2891–2898PubMed
103.
Schneider EM, Lorenz I, Walther P, Janka-Schaub GE (2003) Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? J Pediatr Hematol Oncol 25:680–683PubMed
104.
Schneider P, Greene V, Kanold J, Vannier JP (2001) Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis. Arch Dis Child 84:373PubMed
105.
Shiflett SL, Kaplan J, Ward DM (2002) Chediak-Higashi Syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res 15:251–257PubMed
106.
Shinoda J, Murase S, Takenaka K, Sakai N (2005) Isolated central nervous system hemophagocytic lymphohistiocytosis: case report. Neurosurgery 56:187PubMed
107.
Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A (1993) Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 82:2319–2323PubMed
108.
Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40:1285–1292
109.
Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM (1993) Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11:451–456PubMed
110.
Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957–1959PubMed
111.
Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59PubMed
112.
Sullivan KE, Delaat CA, Douglas SD, Filipovich AH (1998) Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 44:465–468PubMed
113.
Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukura H, Shinozaki K, Kimura H, Matsui A, Miyawaki T (2001) SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood 98:1268–1270PubMed
114.
Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, Kinukawa N, Ohshima K, Kohno K, Kurimoto M, Hara T (1999) Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol 106:182–189PubMed
115.
Takei M, Ishiwata T, Mitamura K, Fujiwara S, Sasaki K, Nishi T, Kuga T, Ookubo T, Horie T, Ryu J, Ohi H, Sawada S (2001) Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol 13:559–565PubMed
116.
Teruya-Feldstein J, Setsuda J, Yao X, Kingma DW, Straus S, Tosato G, Jaffe ES (1999) MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. Lab Invest 79:1583–1590PubMed
117.
Tomaske M, Amon O, Bosk A, Handgretinger R, Schneider EM, Niethammer D (2002) Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 38:141–142PubMed
118.
Ueda I, Ishii E, Morimoto A, Ohga S, Sako M, Imashuku S (2006) Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL). Pediatr Blood Cancer 46:482–488PubMed
119.
Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA (2005) Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7:R30–R37PubMed
120.
Woltman AM, Massacrier C, de Fijter JW, Caux C, van Kooten C (2002) Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J Immunol 168:6181–6188PubMed
121.
Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W (2003) Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) 42:375–379
122.
Zur Stadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G, Hennies HC (2006) Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 27:62–68PubMed
123.
Zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, Kabisch H, Schneppenheim R, Nurnberg P, Janka G, Hennies HC (2005) Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 14:827–834PubMed
Metadaten
Titel
Familial and acquired hemophagocytic lymphohistiocytosis
verfasst von
Gritta E. Janka
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 2/2007
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-006-0258-1

Weitere Artikel der Ausgabe 2/2007

European Journal of Pediatrics 2/2007 Zur Ausgabe

Short Report

Duration of isolation of children with influenza A treated with oseltamivir

Review

Familial recurrence of congenital heart disease: an overview and review of the literature

Original Paper

Hypokalemic rhabdomyolysis in a child due to amphotericin B therapy

Original Paper

Childhood vasculitis and plasma exchange

Erratum

Incidence of type 1 diabetes mellitus in children in Tuzla Canton between 1995 and 2004

Short Report

Spontaneous perforation of the extrahepatic bile duct in infancy: report of two cases and literature review

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise